Imaging diagnosis of brain metastasis

Ramon Barajas, Soonmee Cha

Research output: Chapter in Book/Report/Conference proceedingChapter

35 Citations (Scopus)

Abstract

Hematogeneous spread of primary neoplasm can result in central nervous system (CNS) disease burde various anatomically distinct regions; calvarial, pachymeningeal, leptomeningeal, and intraparenchymal. The choice of imaging modality is dependent on the individual clinical situation, but, largely depends on the patients overall clinical status and the information needed to make . Contrastenhanced magnetic resonance (MR) imaging is the preferred imaging modality; however, computed tomography (CT) is often utilized as the firstpass screening modality disease. Despite the superior soft tissue resolution, multiplanar capability, and of MR imaging, T1-and T2-weighted sequences are limited to delineating morphologic of tissues by tumor. Several physiology based MR imaging sequences have which compliment anatomic MR imaging. Proton magnetic resonance spectroscopic susceptibility contrastenhanced perfusionweighted imaging are two which add additional diagnostic information allowing for improved tumor characterization. Common pitfalls in evaluating for metastatic disease burden include the misidentification -neoplastic hematomas, remote microvascular ischemia, and acute onset of ischemic stroke. pediatric population, CNS metastases are rare; however, the onset of acute neurological a child with known primary tumor should prompt imaging of the neuroaxis.

Original languageEnglish (US)
Title of host publicationCurrent and Future Management of Brain Metastasis
PublisherS. Karger AG
Pages55-73
Number of pages19
Volume25
ISBN (Print)9783805596183, 9783805596176
DOIs
StatePublished - Jan 10 2012
Externally publishedYes

Fingerprint

Neuroimaging
Magnetic Resonance Imaging
Neoplasm Metastasis
Neoplasms
Central Nervous System Diseases
Hematoma
Protons
Magnetic Resonance Spectroscopy
Ischemia
Central Nervous System
Stroke
Tomography
Pediatrics
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Barajas, R., & Cha, S. (2012). Imaging diagnosis of brain metastasis. In Current and Future Management of Brain Metastasis (Vol. 25, pp. 55-73). S. Karger AG. https://doi.org/10.1159/000331174

Imaging diagnosis of brain metastasis. / Barajas, Ramon; Cha, Soonmee.

Current and Future Management of Brain Metastasis. Vol. 25 S. Karger AG, 2012. p. 55-73.

Research output: Chapter in Book/Report/Conference proceedingChapter

Barajas, R & Cha, S 2012, Imaging diagnosis of brain metastasis. in Current and Future Management of Brain Metastasis. vol. 25, S. Karger AG, pp. 55-73. https://doi.org/10.1159/000331174
Barajas R, Cha S. Imaging diagnosis of brain metastasis. In Current and Future Management of Brain Metastasis. Vol. 25. S. Karger AG. 2012. p. 55-73 https://doi.org/10.1159/000331174
Barajas, Ramon ; Cha, Soonmee. / Imaging diagnosis of brain metastasis. Current and Future Management of Brain Metastasis. Vol. 25 S. Karger AG, 2012. pp. 55-73
@inbook{6b2243feda06422e9fbcac32f041ee63,
title = "Imaging diagnosis of brain metastasis",
abstract = "Hematogeneous spread of primary neoplasm can result in central nervous system (CNS) disease burde various anatomically distinct regions; calvarial, pachymeningeal, leptomeningeal, and intraparenchymal. The choice of imaging modality is dependent on the individual clinical situation, but, largely depends on the patients overall clinical status and the information needed to make . Contrastenhanced magnetic resonance (MR) imaging is the preferred imaging modality; however, computed tomography (CT) is often utilized as the firstpass screening modality disease. Despite the superior soft tissue resolution, multiplanar capability, and of MR imaging, T1-and T2-weighted sequences are limited to delineating morphologic of tissues by tumor. Several physiology based MR imaging sequences have which compliment anatomic MR imaging. Proton magnetic resonance spectroscopic susceptibility contrastenhanced perfusionweighted imaging are two which add additional diagnostic information allowing for improved tumor characterization. Common pitfalls in evaluating for metastatic disease burden include the misidentification -neoplastic hematomas, remote microvascular ischemia, and acute onset of ischemic stroke. pediatric population, CNS metastases are rare; however, the onset of acute neurological a child with known primary tumor should prompt imaging of the neuroaxis.",
author = "Ramon Barajas and Soonmee Cha",
year = "2012",
month = "1",
day = "10",
doi = "10.1159/000331174",
language = "English (US)",
isbn = "9783805596183",
volume = "25",
pages = "55--73",
booktitle = "Current and Future Management of Brain Metastasis",
publisher = "S. Karger AG",

}

TY - CHAP

T1 - Imaging diagnosis of brain metastasis

AU - Barajas, Ramon

AU - Cha, Soonmee

PY - 2012/1/10

Y1 - 2012/1/10

N2 - Hematogeneous spread of primary neoplasm can result in central nervous system (CNS) disease burde various anatomically distinct regions; calvarial, pachymeningeal, leptomeningeal, and intraparenchymal. The choice of imaging modality is dependent on the individual clinical situation, but, largely depends on the patients overall clinical status and the information needed to make . Contrastenhanced magnetic resonance (MR) imaging is the preferred imaging modality; however, computed tomography (CT) is often utilized as the firstpass screening modality disease. Despite the superior soft tissue resolution, multiplanar capability, and of MR imaging, T1-and T2-weighted sequences are limited to delineating morphologic of tissues by tumor. Several physiology based MR imaging sequences have which compliment anatomic MR imaging. Proton magnetic resonance spectroscopic susceptibility contrastenhanced perfusionweighted imaging are two which add additional diagnostic information allowing for improved tumor characterization. Common pitfalls in evaluating for metastatic disease burden include the misidentification -neoplastic hematomas, remote microvascular ischemia, and acute onset of ischemic stroke. pediatric population, CNS metastases are rare; however, the onset of acute neurological a child with known primary tumor should prompt imaging of the neuroaxis.

AB - Hematogeneous spread of primary neoplasm can result in central nervous system (CNS) disease burde various anatomically distinct regions; calvarial, pachymeningeal, leptomeningeal, and intraparenchymal. The choice of imaging modality is dependent on the individual clinical situation, but, largely depends on the patients overall clinical status and the information needed to make . Contrastenhanced magnetic resonance (MR) imaging is the preferred imaging modality; however, computed tomography (CT) is often utilized as the firstpass screening modality disease. Despite the superior soft tissue resolution, multiplanar capability, and of MR imaging, T1-and T2-weighted sequences are limited to delineating morphologic of tissues by tumor. Several physiology based MR imaging sequences have which compliment anatomic MR imaging. Proton magnetic resonance spectroscopic susceptibility contrastenhanced perfusionweighted imaging are two which add additional diagnostic information allowing for improved tumor characterization. Common pitfalls in evaluating for metastatic disease burden include the misidentification -neoplastic hematomas, remote microvascular ischemia, and acute onset of ischemic stroke. pediatric population, CNS metastases are rare; however, the onset of acute neurological a child with known primary tumor should prompt imaging of the neuroaxis.

UR - http://www.scopus.com/inward/record.url?scp=84905905154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905905154&partnerID=8YFLogxK

U2 - 10.1159/000331174

DO - 10.1159/000331174

M3 - Chapter

SN - 9783805596183

SN - 9783805596176

VL - 25

SP - 55

EP - 73

BT - Current and Future Management of Brain Metastasis

PB - S. Karger AG

ER -